Refine
Document Type
- Patent (4)
- Article (3)
- Book (2)
- Part of a Book (2)
- Conference Proceeding (1)
The Lehrstuhl für Wärmeübertragung und Klimatechnik at the Aachen University of Technology operates several test facilities to investigate fundamentals of heat and mass transfer supported by the Deutsche Forschungsgemeinschaft, the Minister für Forschung und Technologie and the industry. In order to get high-resolution and reproselection of hardware components is as critical as the design of software routines to perform successful and accurate measurements. In the following the development of the measurement and control system for three different test facilities is presented and discussed. Special attention is given to the education of students within the framework of laboratories and scientific experiments.
The molecular events during nongenotoxic carcinogenesis and their temporal order are poorly understood but thought to include long-lasting perturbations of gene expression. Here, we have investigated the temporal sequence of molecular and pathological perturbations at early stages of phenobarbital (PB) mediated liver tumor promotion in vivo. Molecular profiling (mRNA, microRNA [miRNA], DNA methylation, and proteins) of mouse liver during 13 weeks of PB treatment revealed progressive increases in hepatic expression of long noncoding RNAs and miRNAs originating from the Dlk1-Dio3 imprinted gene cluster, a locus that has recently been associated with stem cell pluripotency in mice and various neoplasms in humans. PB induction of the Dlk1-Dio3 cluster noncoding RNA (ncRNA) Meg3 was localized to glutamine synthetase-positive hypertrophic perivenous hepatocytes, sug- gesting a role for β-catenin signaling in the dysregulation of Dlk1-Dio3 ncRNAs. The carcinogenic relevance of Dlk1-Dio3 locus ncRNA induction was further supported by in vivo genetic dependence on constitutive androstane receptor and β-catenin pathways. Our data identify Dlk1-Dio3 ncRNAs as novel candidate early biomarkers for mouse liver tumor promotion and provide new opportunities for assessing the carcinogenic potential of novel compounds.